Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due ...

Annemarie Hanekamp has overseen some of the most transformative changes in oncology over her years in Big Pharma. Now, she ...

More about BioNTech SE BioNTech SE is a biotechnology company primarily focused on developing and manufacturing immunotherapies for the treatment of cancer and infectious diseases. The company is well ...

Executing in oncology with investigational BNT327/PM8002 combinations and mRNA cancer immunotherapy candidates as pan-tumor treatment approaches ...

Executing in oncology with investigational BNT327/PM8002 combinations and mRNA cancer immunotherapy candidates as pan-tumor treatment approaches BioNTech aims to develop BNT327/PM8002 as a next-genera ...

RNA is a long, polymeric molecule, composed of four different building blocks called nucleotides. In the last decade mRNA has progressed into a promising new class of medicine, with the potential to ...

Investors are weighing Nvidia's big AI plans and puzzling over Trump's tariff policy in the wait for fresh jobs data.

The acquisition also beefs up BioNTech's R&D and manufacturing capabilities in China, adding over 300 Biotheus employees to its ranks. It's a bold move aimed at dominating a high-potential market.

Investors are weighing Nvidia's big AI plans and puzzling over Trump's tariff policy in the wait for fresh jobs data.

Biotech stocks are poised for an exciting 2025 as experts watch for new weight-loss drugs, AI's impact and Trump's second ...

GEN uncovers seven biopharma-related trends based on interviews with experts and other industry stakeholders, as well as ...

BioNTech already owned part of InstaDeep as ... hub in Asia – located initially in Taiwan – along with an mRNA manufacturing unit in Singapore, according to the company's JPM update.